For long-term weight management Semaglutide is generally a better option
The ranges you will see in this guide come from two sources: preclinical research, which is mostly rodent and cell-culture work, and clinical-practice observation, meaning what providers and patients consistently report

Baseline bloodwork CBC, CRP, ferritin, IL-6, cortisol AM, metabolic panel, thyroid function Cardiovascular assessment heart rate variability, orthostatic vitals if POTS is suspected Gut health markers stool testing, zonulin, calprotectin if GI symptoms are prominent Mitochondrial function proxies lactate, organic acids panel if PEM is a primary complaint From there, a typical protocol might be structured as: Phase 1 (Weeks 16): Immune and gut foundation Thymosin Alpha-1: 1.6 mg subcutaneous, twice weekly BPC-157: 250500 mcg daily, route determined by predominant symptom (oral for gut, injectable for systemic) Phase 2 (Weeks 412): Tissue repair and cardiovascular recovery TB-500: 2.02.5 mg subcutaneous, twice weekly Continue BPC-157 as indicated Phase 3 (Weeks 816): Maintenance and metabolic support Taper or pulse doses based on clinical response Add mitochondrial support if fatigue persists (see: Mitochondrial Peptides and Insulin Resistance) These are illustrative dosing ranges based on clinical research and published protocols

This compound is integral in medical environments for several reasons: Sterility and Safety : Helps maintain a sterile environment during medical procedures
J Clin Invest 113 : 2527 Heffernan M et al
The MIC filled by Complete Pharmacy out of Miami via USShots from Seattle had a 25mg/50mg/50mg configuration